0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Marketplace
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Barbiturate Drugs Market Size, Trends, and Future Industry ProspectsPharmaceutical distribution networks are expanding globally, making barbiturate medications more accessible in hospitals and pharmacies. Efficient supply chains help ensure timely availability for critical treatments. This logistical improvement is strengthening the market. The Barbiturate Drugs Market is projected to register a CAGR of 3.6% from 2025 to 2031, expanding from US$ XX million in...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Biosimilars Market Opportunities for Pharma and Biotech CompaniesThe increasing role of biosimilars in hospital treatment protocols is another factor driving market growth. Hospitals are adopting biosimilars to manage healthcare budgets effectively. This shift is improving patient access to essential biologic therapies. The global Biosimilars Market is experiencing remarkable growth as healthcare systems increasingly adopt cost-effective alternatives...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
CAR-T Cell Therapy Market Demand Rising Across Global HealthcareExpanding healthcare infrastructure in emerging economies is creating new opportunities for the CAR-T cell therapy market. Countries in Asia-Pacific and Latin America are investing in advanced cancer treatment facilities. This expansion supports global market growth. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 with 17.5% CAGR The global CAR-T Cell Therapy Market is witnessing...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Комментарии 0 Поделились 27 Просмотры 0 предпросмотр
-
Ceftazidime Avibactam Market Growth & CAGR 9.7% ForecastAccording to a newly published market research report by 24LifeSciences, global Ceftazidime Avibactam market was valued at USD 1.2 billion in 2025 and is projected to reach USD 2.8 billion by 2034, growing at a compound annual growth rate (CAGR) of 9.7% during the forecast period 20262034. Ceftazidime Avibactam is a fixed-dose combination antibiotic incorporating ceftazidime (3rd...0 Комментарии 0 Поделились 24 Просмотры 0 предпросмотр
-
Epilepsy Market Size Research Report: Strategic Insights for Healthcare StakeholdersStrategic collaborations among pharmaceutical companies are boosting innovation in epilepsy therapies. Partnerships help accelerate research and drug development. This trend is expanding the epilepsy market size. The epilepsy market is expanding steadily as the prevalence of neurological disorders continues to rise worldwide. The market is projected to grow from US$ 7.7 billion in 2022 to US$...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Innovative Drug Development Shaping the Complex Regional Pain Syndrome MarketThe expansion of healthcare infrastructure in emerging economies is creating new opportunities for the CRPS treatment market. Improved hospital facilities and specialist care are helping more patients access treatment. This trend supports global market growth. The Complex Regional Pain Syndrome (CRPS) Market is experiencing steady growth as the demand for effective chronic pain management...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Investment Trends in the Anti-cancer Drugs MarketThe increasing focus on biologics and biosimilars is transforming the anti-cancer drugs industry. These advanced therapies offer new treatment options for patients with complex cancers. Their rising adoption is expected to drive long-term market expansion. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and increasing...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Market Drivers and Challenges in the Chemotherapy-Induced Peripheral Neuropathy MarketGovernment initiatives and funding programs for cancer research are further contributing to the growth of the chemotherapy-induced peripheral neuropathy market. Increased financial support encourages the development of innovative therapies and clinical studies. The chemotherapy-induced peripheral neuropathy (CIPN) treatment market is gaining significant attention within the global healthcare...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Pharma R&D Investments Accelerating Antiulcerant Drugs MarketIncreasing research activities focused on gastrointestinal disorders are contributing to better understanding and management of ulcers. Scientists and medical experts are exploring advanced therapeutic approaches to improve treatment outcomes. These efforts are encouraging innovation in the antiulcerant drugs market. The Antiulcerant Drugs Market is projected to reach US$ 51.01 billion by 2031,...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Pharmaceutical Manufacturing Market Competitive Landscape, Differentiation Strategies and Forecast to 2033Pharmaceutical Manufacturing Industry Outlook: Straits Research has added a report titled “Global Pharmaceutical Manufacturing Market Professional Report 2025-2033” to its database of research reports. The study provides complete details about the usage and adoption of Pharmaceutical Manufacturing in various industrial applications and geographies. This helps the key stakeholders...0 Комментарии 0 Поделились 786 Просмотры 0 предпросмотр
Расширенные страницы
Спонсоры
Спонсоры
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek